Over 7,500 medications in stock!
100% Original medicines of Russian and world brands
Fast international shipping and delivery!
Free shipping order $150
24/7 Customer support

ARLEVERT™ tablets 40mg+20mg, 50pcs

🔥 8 items sold in last 3 hours
19 people are viewing this product
  • Arlevert™ Tablets 40Mg+20Mg, 50Pcs Buy Online 4
  • Arlevert™ Tablets 40Mg+20Mg, 50Pcs Buy Online 6
  • Arlevert™ Tablets 40Mg+20Mg, 50Pcs Buy Online 8
Brand:

$110.0

or
Buy from 5 to 10 items and get 2% OFF
on each product
Buy from 11 to 30 items and get 5% OFF
on each product
Buy from 31 to 100 items and get 10% OFF
on each product
Buy from 101 to ∞ items and get 15% OFF
on each product

All forms of

ARLEVERT™ tablets 40mg+20mg, 20pcs

$50.5
Add to cart

Analogs of ARLEVERT™

AVIAMARIN™ tablets 50mg, 10pcs

$17.5
Add to cart

DRAMINA™ tablets 50mg, 10pcs

$22.5
Add to cart

COMBITROPIL™ capsules 400mg+25mg, 30pcs

$24.0
Add to cart

NOOKAM™ capsules 400mg+25mg, 60pcs

$26.5
Add to cart

Table of Contents

ARLEVERT™ 40mg+20mg 50 Tablets Buy Online

ARLEVERT Tablets: Understanding This Medication

Experiencing persistent dizziness and nausea can significantly impact your daily life. ARLEVERT tablets offer a potential solution by targeting the underlying causes of these debilitating symptoms. This medication combines two active ingredients working synergistically to provide relief.

This comprehensive guide will explore the key aspects of ARLEVERT, helping you understand its mechanism of action, appropriate uses, and potential side effects. Remember to always consult your physician before starting any new medication.

Understanding ARLEVERT’s unique formulation is crucial for effective management of dizziness and nausea. The combined action of its components makes it a powerful tool in addressing these common ailments.

The unsettling sensations of dizziness and nausea can significantly disrupt daily life, impacting work, social interactions, and overall well-being. These symptoms, often stemming from various underlying conditions, can range from mild discomfort to debilitating episodes. For many, finding effective relief is paramount to regaining a sense of normalcy and control.

ARLEVERT tablets offer a targeted approach to managing these distressing symptoms. This medication is a carefully formulated combination of two active ingredients: cinnarizine, a calcium channel blocker, and dimenhydrinate, an antihistamine. This unique combination works on multiple levels to address the root causes of dizziness and nausea, providing comprehensive relief.

This dual-action mechanism differentiates ARLEVERT from single-ingredient medications. While many treatments focus on just one aspect of the problem, ARLEVERT tackles both the vestibular system (responsible for balance) and the central nervous system (involved in nausea). This multi-pronged approach contributes to its efficacy in providing effective and lasting relief for many patients.

This detailed examination of ARLEVERT will delve into its precise mechanism of action, clinical applications, and important safety considerations. Understanding these factors will empower patients and healthcare providers to make informed decisions regarding its use. Remember that individual responses to medication can vary, and consulting a healthcare professional is essential before starting any new treatment.

Mechanism of Action: A Two-Pronged Approach

ARLEVERT’s effectiveness stems from its unique combination of cinnarizine and dimenhydrinate, each targeting different aspects of dizziness and nausea. Cinnarizine, a calcium channel blocker, acts primarily on the vestibular system, the part of the inner ear responsible for balance and spatial orientation. By modulating calcium influx into vestibular cells, cinnarizine reduces the excessive stimulation that can lead to feelings of dizziness and vertigo.

Dimenhydrinate, an antihistamine with strong anticholinergic properties, complements cinnarizine’s action by targeting the central nervous system. It works by blocking histamine receptors in the brain, thereby reducing nausea and vomiting. Its anticholinergic effects further contribute to motion sickness relief by inhibiting the activity of certain neurotransmitters in the brain.

The synergistic effect of these two components is what makes ARLEVERT so effective. Cinnarizine directly addresses the peripheral causes of dizziness, while dimenhydrinate tackles the central nervous system components of nausea and vomiting. This two-pronged approach offers comprehensive relief from the often intertwined symptoms of vertigo and nausea, providing a more complete solution than single-agent therapies.

It’s important to note that while ARLEVERT works effectively for many individuals, the precise mechanisms underlying its action are complex and multifaceted. Further research continues to unravel the intricate interplay between these two active ingredients and their impact on the body’s response to dizziness and nausea. Understanding this complexity underscores the importance of consulting a healthcare provider for personalized guidance on its use.

Indications for Use: When ARLEVERT May Be Prescribed

ARLEVERT’s primary indication is the symptomatic treatment of dizziness of various origins. This makes it a valuable tool in managing a range of conditions where dizziness is a prominent feature. The medication’s effectiveness extends beyond simple vertigo, proving beneficial in cases where dizziness is accompanied by nausea and vomiting.

Specific conditions where ARLEVERT may be prescribed include, but are not limited to, vertigo associated with inner ear disorders, Meniere’s disease, and motion sickness. Its ability to alleviate both the spinning sensation of vertigo and the accompanying nausea makes it a suitable choice for patients experiencing these combined symptoms. The medication can also be considered for those experiencing dizziness related to other conditions, always under the guidance of a healthcare professional.

It’s crucial to remember that ARLEVERT is a symptomatic treatment, meaning it addresses the symptoms of dizziness and nausea rather than the underlying cause. Therefore, diagnosis and treatment of the underlying condition remain vital aspects of patient care. The decision to prescribe ARLEVERT should be made by a physician after a thorough assessment of the patient’s medical history and current symptoms.

Before initiating treatment with ARLEVERT, a comprehensive evaluation should be conducted to rule out serious conditions that could mimic the symptoms of dizziness and nausea. The physician will consider the patient’s overall health, potential drug interactions, and other factors to determine the suitability and safety of this medication. This careful approach ensures that ARLEVERT is used appropriately and effectively, maximizing its benefits while minimizing potential risks.

Dosage and Administration: Following Prescribed Guidelines

The recommended dosage of ARLEVERT is typically one tablet three times daily. This regimen is designed to maintain consistent therapeutic levels of both cinnarizine and dimenhydrinate, ensuring effective management of symptoms throughout the day. However, individual needs may vary, and your physician will determine the appropriate dosage based on your specific condition and response to treatment.

It is crucial to adhere strictly to the prescribed dosage and frequency. Adjusting the dosage without consulting your doctor could lead to suboptimal treatment or adverse effects. Never exceed the recommended dose, even if symptoms persist. Consistent adherence to the prescribed regimen is essential for maximizing the therapeutic benefits of ARLEVERT.

ARLEVERT tablets should be taken orally, preferably after meals. Taking the medication with food helps minimize potential gastrointestinal irritation. Swallow the tablets whole with a sufficient amount of water; do not crush or chew them, as this can alter the drug’s release profile and potentially reduce its effectiveness or increase side effects. Regular intake, as directed by your physician, is key to experiencing consistent symptom relief.

The duration of treatment will also be determined by your physician. Generally, treatment should not exceed four weeks without reassessment. Your doctor will monitor your progress and adjust the treatment plan accordingly, considering the effectiveness of the medication and the presence of any side effects. Open communication with your healthcare provider is essential throughout the treatment process.

Precautions and Contraindications: Important Considerations

Before starting ARLEVERT, it’s crucial to inform your doctor about your complete medical history, including any pre-existing conditions or allergies. This is particularly important for individuals with certain health concerns where ARLEVERT may pose a risk. Open communication with your physician is essential for safe and effective medication management.

ARLEVERT is contraindicated in patients with severe kidney or liver impairment, as these organs play a crucial role in the metabolism and excretion of the drug’s components. Individuals with a history of prostatic hyperplasia or urinary retention should also exercise caution, as the anticholinergic properties of dimenhydrinate may exacerbate these conditions. Pregnant or breastfeeding women should absolutely avoid ARLEVERT due to potential risks to the fetus or infant.

Patients with glaucoma (increased intraocular pressure), severe cardiovascular disease, or Parkinson’s disease should use ARLEVERT with extreme caution and only under strict medical supervision. The medication should be used with care in patients with even mild kidney or liver impairment. The potential for drug interactions necessitates a thorough review of all medications currently being taken.

ARLEVERT may cause drowsiness, especially during the initial stages of treatment. Patients should avoid driving or operating machinery until they know how the medication affects them. The medication can also potentially mask the symptoms of ototoxicity (hearing damage) if used concurrently with aminoglycoside antibiotics. Therefore, close monitoring is crucial during concurrent use of these medications. Always prioritize safety and consult your physician for personalized guidance.

Possible Side Effects: Being Aware of Potential Risks

While ARLEVERT is generally well-tolerated, like all medications, it can cause side effects. The most commonly reported side effects are generally mild and transient, resolving spontaneously within a few days even with continued treatment. However, it’s crucial to be aware of these potential effects and report any concerning symptoms to your physician immediately.

Sedation, including drowsiness, fatigue, and lethargy, is a frequently observed side effect, particularly during the initial phase of treatment. This effect is often dose-related, meaning it may be more pronounced at higher doses. Other potential side effects include dry mouth, a common occurrence with anticholinergic medications. Less frequent but still possible side effects include gastrointestinal disturbances such as nausea, constipation, or diarrhea.

In rarer instances, more serious side effects can occur. These are less common but require immediate medical attention if experienced. Such effects might include extrapyramidal symptoms (involuntary movements), allergic reactions (ranging from mild skin rashes to severe anaphylaxis), and cardiovascular effects (though rare, particularly in patients with pre-existing heart conditions). These serious side effects necessitate prompt medical evaluation and potential discontinuation of the medication.

It is essential to remember that the frequency and severity of side effects can vary significantly between individuals. Factors such as age, underlying health conditions, and concurrent medication use can influence the likelihood and intensity of side effects. This highlights the importance of open communication with your healthcare provider to discuss any concerns or unusual symptoms you may experience while taking ARLEVERT. Early detection and management of side effects are crucial for ensuring patient safety and treatment efficacy.

Drug Interactions: Avoiding Potential Complications

The potential for drug interactions is a significant consideration when using ARLEVERT. Because ARLEVERT contains both cinnarizine and dimenhydrinate, which are metabolized by the liver and interact with various other medications, it’s crucial to inform your doctor about all other medications, supplements, or herbal remedies you are currently taking. This comprehensive disclosure is essential for preventing potentially dangerous interactions.

Concurrent use of ARLEVERT with central nervous system depressants, such as sedatives, tranquilizers, or alcohol, can significantly enhance the sedative effects of ARLEVERT, potentially leading to excessive drowsiness or impairment. This combination should be avoided or carefully monitored by your physician. Similarly, ARLEVERT may interact with antihypertensive medications, potentially leading to an additive hypotensive effect resulting in dangerously low blood pressure.

ARLEVERT’s anticholinergic properties can interact negatively with other anticholinergic drugs, potentially exacerbating side effects such as dry mouth, constipation, and urinary retention. Therefore, combined use with medications possessing similar effects should be approached with extreme caution and only under close medical supervision. In addition, ARLEVERT may interfere with allergy skin testing, potentially yielding false-negative results. This necessitates careful consideration when allergy testing is scheduled.

Given the complexity of potential drug interactions, it’s paramount to provide your physician with a complete list of all medications and supplements you are using. This allows for a thorough assessment of potential interactions and enables your doctor to make informed decisions about the suitability and safety of prescribing ARLEVERT. This proactive approach significantly contributes to safe and effective medication management.

Pros

ARLEVERT offers several advantages in managing dizziness and nausea. Its dual mechanism of action, targeting both the peripheral and central nervous systems, provides comprehensive symptom relief. This multi-pronged approach often proves more effective than single-agent therapies, addressing both the spinning sensation of vertigo and the accompanying nausea and vomiting.

Many patients experience a significant reduction in the severity and frequency of their dizziness and nausea episodes. This improvement in symptom control can lead to a substantial enhancement in their quality of life, allowing them to participate more fully in daily activities and social interactions. The improved ability to function contributes to a greater sense of overall well-being and independence.

ARLEVERT’s relatively convenient oral administration makes it easy to incorporate into a daily routine. The typical dosage regimen, involving three tablets daily, is manageable for most patients. This ease of use contributes to improved patient compliance and enhances the likelihood of achieving therapeutic benefits. The tablet form is also generally well-tolerated.

While side effects are possible, many patients experience only mild and transient symptoms. The majority of adverse effects are generally manageable and do not necessitate discontinuation of the medication. The relatively favorable safety profile further enhances ARLEVERT’s appeal as a treatment option for dizziness and nausea. However, individual responses can vary, and close monitoring by a healthcare professional is always recommended.

A Valuable Tool When Used Appropriately

Cons

Despite its effectiveness for many, ARLEVERT does have potential drawbacks. The most common concern is sedation, which can manifest as drowsiness, fatigue, or lethargy. This side effect can impair cognitive function and reaction time, making it unsafe to operate machinery or drive while taking the medication. This necessitates caution and awareness of potential impairment.

Other side effects, while less frequent, can still impact daily life. Dry mouth is a common anticholinergic side effect that can lead to discomfort and difficulties with speaking or swallowing. Gastrointestinal issues, such as constipation or diarrhea, can also occur, although these are usually mild and transient. The potential for these side effects underscores the importance of open communication with your physician.

ARLEVERT is contraindicated in individuals with severe kidney or liver disease, limiting its use in patients with these conditions. Pregnant or breastfeeding women should also avoid the medication due to potential risks. These contraindications highlight the importance of a thorough medical assessment before starting ARLEVERT therapy. Careful consideration of these limitations is essential for patient safety.

Finally, the potential for drug interactions represents a significant consideration. ARLEVERT’s components can interact negatively with various medications, potentially leading to adverse effects or reduced efficacy. Therefore, providing your physician with a complete list of all medications, supplements, and herbal remedies you are taking is crucial to ensure safe and effective use of ARLEVERT. This thorough approach minimizes the risk of unforeseen complications.

  • Arlevert™ Tablets 40Mg+20Mg, 50Pcs Buy Online 10
    [Author]

    Georgia Austin is a seasoned SEO content writer, editor, and content marketing strategist with over 7 years of experience crafting compelling copy for leading brands in the healthcare and pharmaceutic...

    View all posts
  • Arlevert™ Tablets 40Mg+20Mg, 50Pcs Buy Online 12
    [Editor]

    Jonathan Brown is a seasoned professional editor, researcher, and educator with over 12 years of experience helping authors find their voice and polish their writing. As a content editor for RxPulsar....

    View all posts
  • Arlevert™ Tablets 40Mg+20Mg, 50Pcs Buy Online 14
    [Medical reviewer]

    Dr. David J. Bronster, MD, is a distinguished Professor of Neurology and Neurological Consultant to the Recanati/Miller Transplantation Institute. With an impressive 36-year career in consultative wor...

    View all posts

Reviews

There are no reviews yet.

Be the first to review “ARLEVERT™ tablets 40mg+20mg, 50pcs”

Your email address will not be published. Required fields are marked

Similar products

PHENIBUT™ tablets 250mg, 20pcs

$30.5
Add to cart

TOFISOPAM-SZ™ tablets 50mg, 20pcs

$22.5
Add to cart

TOFISOPAM-SZ™ tablets 50mg, 60pcs

$41.0
Add to cart

TENOTEN™ KIDS dissolving tablets, 40pcs

$45.0
Add to cart

TENOTEN™ dissolving tablets, 40pcs

$42.5
Add to cart

RELATOX™ lyophilisate for injection solution 100U, 1pc

$939.0
Add to cart

RELATOX™ lyophilisate for injection solution 50U, 1pc

$547.0
Add to cart

NERVOHEEL™ sublingual tablets, 50pcs

$52.0
Add to cart

NEYPILEPT™ oral solution 100mg/ml (300ml), 1pc

$277.5
Add to cart

XEOMIN™ powder for injection solution 100U, 1pc

$896.5
Add to cart

QUENTIAX™ SR prolonged-release tablets 300mg, 60pcs

$174.5
Add to cart

CARNILAND™ sublingual drops 25ml, 1pc

$24.0
Add to cart

KALIMIN™ 60 N tablets 60mg, 100pcs

$75.5
Add to cart

IPIDACRINE-SZ™ tablets 20mg, 50pcs

$71.5
Add to cart

DYSPORT™ powder for injection solution 300U, 1pc

$869.0
Add to cart

DYSPORT™ powder for injection solution 500U, 1pc

$1,434.0
Add to cart

HYDROXYZINE tablets 25mg, 25pcs

$9.5
Add to cart

GABAPENTIN™-SZ™ capsules 300mg, 100pcs

$71.5
Add to cart

VALERIAN rhizomes with roots 1.5g, filter bags 20pcs

$13.5
Add to cart
Select your currency